Superior vena cava syndrome radiation therapy: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Superior vena cava syndrome}}
{{Superior vena cava syndrome}}
{{CMG}}
{{CMG}}{{AE}}{{MV}}


Please help WikiDoc by adding more content here.  It's easy!  Click  [[Help:How_to_Edit_a_Page|here]] to learn about editing.
==Overview==
 
Rapid radiotherapy  is recommended for all patients who develop superior vena cava syndrome secondary to malignant tumor. The feasibility of radiation therapy depends on the stage of cancer at diagnosis. Radiation dosage will depend on a basis of clinical features.
==Radiation Therapy==
 
==Indications==
 
The feasibility of radiation therapy depends on the stage of cancer at diagnosis. If the obstruction caused by the SVCS is caused by a [[tumor]] that is not sensitive to [[chemotherapy]], radiation therapy is indicated


==Overview==
===Emergent RT===
If the obstruction of the [[SVC]] is caused by a [[tumor]] that is not sensitive to [[chemotherapy]], radiation therapy should be given. Treatment with larger fractions of [[radiation]] is thought to be beneficial in developing a rapid response. One study shows, however, that there is no obvious need for large radiation fraction sizes for the first few radiation treatments as was previously believed. Many fractionation schemes have been used, with doses ranging from 30 Gy in 10 fractions to 50 Gy in 25 fractions. Relief of symptoms in small cell [[lung cancer]] is reported to be 62% to 80%, whereas in non-small cell [[lung cancer]], approximately 46% of the patients experienced symptomatic relief. In one study, more than 90% of the patients achieved a partial or complete response with a 3-week regimen of 8 Gy given once a week for a total dose of 24 Gy.
*RT prior to biopsy can obscure histologic diagnosis.
*Endovascular stents in severely symptomatic patients provide more rapid relief
*Consider Emergency RT (and endovascular stent) if:
**Stridor from severe laryngeal edema
**Coma from cerebral edema
 
===RT dose/schedule===
Initially use high-dose fractions (3-4 Gy) for 2 or 3 days if treating curatively to 60-70Gy, followed by standard 1.8-2 Gy/fx
*Not unusual to palliate with 3Gy x 10, or 4Gy x 5 or 2.5Gy x 15
*Symptomatic relief can be apparent in 72 hours, complete relief can be seen by 2 weeks (78% SCLC, 63% NSCLC)
*SVCS patency improvement only in 31%, so some symptom relief probably due to development of collateral circulation over time
*Many patients will recur symptomatically prior to death
*Consider Chemotherapy before or with RT if:
**SCLC, NHL & germ cell tumors
**In the absence of distant metastasis, aggressive management is indicated
**Symptomatic relief within the first 30 days might be a good prognostic factor
**Treatment with larger fractions of [[radiation]] is thought to be beneficial in developing a rapid response.


==References==
==References==
{{Reflist|2}}
{{Reflist|2}}


[[Category:Needs content]]
[[Category:Disease]]
[[Category:Disease]]
[[Category:Otolaryngology]]
[[Category:Hematology]]
[[Category:Hematology]]
[[Category:Cardiology]]
[[Category:Cardiology]]

Revision as of 20:33, 13 January 2016

Superior Vena Cava Syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Superior Vena Cava Syndrome from Other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Radiation Therapy

Surgery

Primary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Superior vena cava syndrome radiation therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Superior vena cava syndrome radiation therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Superior vena cava syndrome radiation therapy

CDC on Superior vena cava syndrome radiation therapy

Superior vena cava syndrome radiation therapy in the news

Blogs on Superior vena cava syndrome radiation therapy

Directions to Hospitals Treating Superior vena cava syndrome

Risk calculators and risk factors for Superior vena cava syndrome radiation therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Maria Fernanda Villarreal, M.D. [2]

Overview

Rapid radiotherapy is recommended for all patients who develop superior vena cava syndrome secondary to malignant tumor. The feasibility of radiation therapy depends on the stage of cancer at diagnosis. Radiation dosage will depend on a basis of clinical features.

Radiation Therapy

Indications

The feasibility of radiation therapy depends on the stage of cancer at diagnosis. If the obstruction caused by the SVCS is caused by a tumor that is not sensitive to chemotherapy, radiation therapy is indicated

Emergent RT

  • RT prior to biopsy can obscure histologic diagnosis.
  • Endovascular stents in severely symptomatic patients provide more rapid relief
  • Consider Emergency RT (and endovascular stent) if:
    • Stridor from severe laryngeal edema
    • Coma from cerebral edema

RT dose/schedule

Initially use high-dose fractions (3-4 Gy) for 2 or 3 days if treating curatively to 60-70Gy, followed by standard 1.8-2 Gy/fx

  • Not unusual to palliate with 3Gy x 10, or 4Gy x 5 or 2.5Gy x 15
  • Symptomatic relief can be apparent in 72 hours, complete relief can be seen by 2 weeks (78% SCLC, 63% NSCLC)
  • SVCS patency improvement only in 31%, so some symptom relief probably due to development of collateral circulation over time
  • Many patients will recur symptomatically prior to death
  • Consider Chemotherapy before or with RT if:
    • SCLC, NHL & germ cell tumors
    • In the absence of distant metastasis, aggressive management is indicated
    • Symptomatic relief within the first 30 days might be a good prognostic factor
    • Treatment with larger fractions of radiation is thought to be beneficial in developing a rapid response.

References

Template:WH Template:WS